Voluntary announcement - nona biosciences develops the world's first language model trained on fully human heavy-chain-only antibodies
Filed with HKEX · Stock code 2142 · · 2 pages · English
和鉑醫藥控股有限公司 HBM Holdings Limited (incorporated in the Cayman Islands with limited liability) (Stock Code: 02142) VOLUNTARY ANNOUNCEMENT ## NONA BIOSCIENCES DEVELOPS THE WORLD’S FIRST ## LANGUAGE MODEL TRAINED ON FULLY HUMAN ## HEAVY-CHAIN-ONLY ANTIBODIES This announcement is made by HBM Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the
Earlier from HBM
- Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
- Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis
- Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results
- Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
- Control Devices Acquires Sherwood Valve
Later from HBM
- Supplemental announcement in relation to the 2025 annual report and the 2026 interim report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Next Day Disclosure Return
- Inside information announcement - nmpa approval of batoclimab injection (subcutaneous injection) for the treatment of generalized myasthenia gravis
Follow HBM into a list and get an email when it puts out news.
Follow HBM